A secret that hides Biocryst Pharmaceuticals Inc.’s strength (NASDAQ:BCRX)

Stocks of Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) traded higher last session on Wall Street, up 10.39% to $5.95. According to the data, Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) has 12 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $30.00 and […]

Before You Invest In Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX), Consider This Metric

Stocks of Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) traded higher last session on Wall Street, down -1.57% to $5.64. According to the data, Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) has 11 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $30.00 and […]

How should investors evaluate BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX)?

Stocks of BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) traded higher last session on Wall Street, up 7.34% to $7.60. BCRX stock price is now 0.08% away from the 50-day moving average and -20.41% away from the 200-day moving average. The market capitalization of the company currently stands at $1.34B. With the price target maintained at $11, Jefferies […]

BioCryst Pharmaceuticals Inc. (BCRX) – Mismatched value: Check Out the Fundamental Analysis

Stocks of BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) traded higher last session on Wall Street, up 3.66% to $7.92. According to the data, BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) has 11 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $30.00 and […]